Defence Therapeutics Inc. (DTC) — Cash Flow-to-Debt Ratio
Defence Therapeutics Inc. (DTC) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of €-1.40 Million could theoretically repay -1% of its total liabilities (€2.59 Million) in one year. See Defence Therapeutics Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Defence Therapeutics Inc. Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Defence Therapeutics Inc. across 5 annual periods. Also explore Defence Therapeutics Inc. (DTC) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Defence Therapeutics Inc. (2020–2024)
Year-by-year debt coverage analysis for Defence Therapeutics Inc.. For market capitalisation and broader financial context, see Defence Therapeutics Inc. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.06x | €-4.29 Million | €4.06 Million | ▲ +72.9% |
| 2023 | -3.89x | €-7.66 Million | €1.97 Million | ▲ +28.7% |
| 2022 | -5.46x | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €122.26K | ▼ -581.7% |
| 2020 | -2.75x | €-132.83K | €48.35K | — |